Hypertension. Section 5-145a C.G.S. is amended to include peace officers covered under Section 29-18, 29-18a, 29-18b, C .G .S . or Section 26-5 C.G.S. and fulltime firefighting personnel. Bargaining Unit employees otherwise covered by Section 5- 145a C .G .S ., upon initial employment, shall be given a physical examination by the State within thirty (30) days of employment . Should the employer fail to give such an examination, the employee shall be deemed to have successfully passed a physical examination for the purpose of Section 5-145a C .G .S . On the effective date of this Agreement, employees for whom there is no record of a physical examination shall be deemed to have successfully passed a physical examination for the purposes of Section 5-145a C .G .S .
Hypertension. The following services related to hypertension are covered with $0 Out-of-Pocket Cost when linked to a primary diagnosis of hypertension and performed by a Network Provider: • Office visits to a Primary Care Provider for routine management of hypertension • Office visits to a Cardiologist (heart specialist) for consultation and routine management of Hypertension • Office visits to a Nephrologist (kidney specialist) for consultation and routine management of Hypertension • Palliative care conversations (chronic condition treatment preferences) with Primary Care Provider, Cardiologist, or Nephrologist • Nutritional counseling up to six (6) visits per year • Targeted laboratory tests for the routine management of hypertension Please note, if you have complications from hypertension and use an emergency department or urgent care center, have a Hospital stay, or get treatment for heart and kidney disease, services will be subject to standard Out-of-Pocket Costs as outlined in your Schedule of Benefits.
Hypertension. Expanded pharmacy coverage is limited to $0 Out-of-Pocket Cost for select Tier 1 preferred generic medications and a reduction in Out-of-Pocket Cost for select Tier 2 and Tier 3 preferred brand medications as outlined below. On plans that apply a Deductible for Tier 2 and Tier 3 medications, the Deductible is waived and the Coinsurance or Copayment is reduced by half. On plans that have a copay for Tier 2 and Tier 3 medications, the copay is reduced by half.
Hypertension. Section 5-145a C.G.S. is amended to include peace officers covered under Section 29-18, 29-18a, 29-18b, C.G.S. or Section 26-5 C.G.S. and fulltime firefighting personnel. Bargaining Unit employees otherwise covered by Section 5- 145a C.G.S., upon initial employment, shall be given a physical examination by the State within thirty (30) days of employment. Should the employer fail to give such an examination, the employee shall be deemed to have successfully passed a physical examination for the purpose of Section 5-145a C.G.S. On the effective date of this Agreement, employees for whom there is no record of a physical examination shall be deemed to have successfully passed a physical examination for the purposes of Section 5-145a C.G.S.
Hypertension. 1.4.2 Heart Failure with Preserved Ejection Fraction (HFpEF)
Hypertension. Section 5-145a C.G.S. is amended to include peace officers covered under Section 29-18, 29-18a, 29-18b, C.G.S. or Section 26-5 C.G.S. and fulltime firefighting personnel. Bargaining Unit employees otherwise covered by Section 5-145a C.G.S., upon initial employment, shall be given a physical examination by the State within thirty (30) days of employment. Should the employer fail to give such an examination, the employee shall be deemed to have
Hypertension. There are at least 970 million people worldwide who have hypertension, with approximately 330 million people in the developed world and 640 million in the developing world documented as having hypertension [242]. The WHO rates hypertension as one of the most important causes of premature death worldwide and the problem is growing. In 2025 it is estimated there will be 1.56 billion adults living with high blood pressure [242]. Hypertension increases the risk for many CV diseases, including stroke, coronary artery disease, heart failure, and peripheral vascular disease [243]. Coronary disease in men and stroke in women are the principal CV events noted after hypertension onset, as reported by the Framingham Heart Study [244].
Hypertension i. The number of enrollees identified as hypertensive using HEDIS measures
Hypertension. Hypertension is a common medical condition in which a person’s blood pressure is chronically elevated and can be classified as either essential (primary) or secondary. Essential hypertension accounts for 90-95% of the cases of hypertension and is defined as hypertension in which no cause underlies the raised blood pressure (Xxxxxxxxx and Xxxxxx, 2000). It is estimated that nearly one billion people are affected by hypertension worldwide, and this figure is predicted to increase to 1.5 billion by 2025 (Xxxxxxx et al., 2005). Secondary hypertension indicates that the hypertension is a result of (ie secondary to) another condition such as kidney disease, tumors or adrenal disease. The British Hypertension Society recommends that drug therapy be started in patients with a sustained systolic blood pressures of greater than or equal to 160 mmHg or sustained diastolic blood pressures of greater than or equal to 100 mmHg despite non-pharmacological measures (Xxxxxxxx et al., 2004). Treatment is recommended as persistent hypertension is a well established risk factor for developing end organ damage typically in the kidneys (Xxxx et al., 2009a), eyes (Xxxx and Xxxxxxxx, 2007), arteries (Xxxxxx, Xx., 2009), brain (Xxxxxxxxxxxx and Xxxxxxx, 2006) and the heart (Xxxxxx et al., 2009; Xxxxxxxxxxxx and Xxxxxxxxxxxxx, 2010). Even though no direct cause is known for essential hypertension there are many risk factors such as sedentary lifestyle (Xxxxx et al., 2006), obesity (Xxxxxx and Ruilope, 2007; Xxxxxxx and Xxxx, 2004), alcohol (Xxxxxxx and Xxxxxxx, 2009), age (Xxxxxx et al., 2009) and genetic mutations (Xxxxxxx and Xxxxxxx, 2006; Xxxx and Xxxxxx, 2006; Xxxxxxx et al., 2000). The mechanism underlying essential hypertension is not well understood but what is known is that with time there is an increase in the total peripheral resistance which results in high blood pressure. One of the proposed theories for this increased total peripheral resistance is an overactive renin-angiotensin system (Figure 1.1) which leads to greater formation of AngiotensinII (AngII) resulting in vasoconstriction of arteries and retention of sodium and water in the kidneys, the net result of which is to increase blood pressure (Xxxxxx et al., 2009). This is supported by genetic linkage between the angiotensinogen gene and hypertension in many studies in which there is the presence of increased levels of plasma angiotensinogen (AngII precursor) in hypertensive subjects (Xxxxx and Xxxxxxx, 2004).
Hypertension. Definition Hypertension is defined as a systolic blood pressure > 140mmHg and/or diastolic blood pressure of >90mmHg. This target may not be suitable for all patients and a more individualised approach may be preferred (e.g. in frail elderly patients).
